Latest in Brain

Image credit:

Medtronic's implantable OCD treatment okayed by FDA

Darren Murph
February 24, 2009
Share
Tweet
Share

Sponsored Links

Looks like those brain pacemaker researchers are a bit late on this one, as folks at Medtronic are apt to get the jump on advanced OCD treatment given a recent FDA approval of their device. Hailed as the first implantable device "designed to deliver electrical therapy to the brain to suppress symptoms associated with severe obsessive-compulsive disorder," the Reclaim DBS (deep brain stimulation) Therapy was said to be able to treat OCD patients in cases where drugs and psychotherapy failed. Understandably, Medtronic is doing everything it can to get the product out by the middle of this year, and following up on its good fortune, it also proclaimed that it had started up a randomized clinical trial of DBS for treatment-resistant depression. There's no mention of an expected price, but apparently only 4,000 or so will be needed each year.

[Via Vos Iz Neias, thanks yossi]



All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.
Share
Tweet
Share

Popular on Engadget

Engadget's 2020 Back-to-School Guide

Engadget's 2020 Back-to-School Guide

View
Facebook used 86 percent renewable energy in 2019

Facebook used 86 percent renewable energy in 2019

View
Amazon Prime Video will soon have the content, but it needs a better home

Amazon Prime Video will soon have the content, but it needs a better home

View
NASA will fund six more Artemis missions as it plans return to the moon

NASA will fund six more Artemis missions as it plans return to the moon

View
Ubisoft posts 'Far Cry 6' teaser starring Giancarlo Esposito

Ubisoft posts 'Far Cry 6' teaser starring Giancarlo Esposito

View

From around the web

Page 1Page 1ear iconeye iconFill 23text filevr